| http://www.w3.org/ns/prov#value | - or after approval, may subject an applicant to a variety of administrative or judicial sanctions, such as the FDA??s refusal to approve pending NDAs, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters, product
|
